SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-04-000731
Filing Date
2004-02-13
Accepted
2004-02-13 14:43:41
Documents
1
Group Members
ABINGWORTH BIOVENTURES III A LPABINGWORTH BIOVENTURES III B LPABINGWORTH BIOVENTURES III C LPABINGWORTH BIOVENTURES III EXECUTIVES LP

Document Format Files

Seq Description Document Type Size
1 3 DIMENSIONAL PHARMACEUTICALS b49503absc13gza.txt SC 13G/A 23463
  Complete submission text file 0000950135-04-000731.txt   25613
Mailing Address 231 VAL DES BONS MALADES BOITE POSTALE 566 L2015 LUXEMBOURG N4
Business Address 231 VAL DES BONS MALADES L-2121 LUXEMBERG-KIRCHBERG N4 3524389891
ABINGWORTH BIOVENTURES SICAV (Filed by) CIK: 0000895906 (see all company filings)

 

Mailing Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341 6104588959
3 DIMENSIONAL PHARMACEUTICALS INC (Subject) CIK: 0000914201 (see all company filings)

IRS No.: 232716487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59449 | Film No.: 04597832
SIC: 2834 Pharmaceutical Preparations